LEADER 01172nam  2200337z- 450 
001 9910689446103321
005 20161209100801.0
035   $a(CKB)5860000000032914
035   $a(BIP)007945709
035   $a(EXLCZ)995860000000032914
100   $a20220406c2001uuuu  -u-         -
101 0 $aeng
200 10$aReview of the anti-drug certification process $ehearing before the Committee on Foreign Relations, United States Senate, One Hundred Seventh Congress, first session, March 1, 2001
215   $a1 online resource (iii, 49 p.) 
311   $a0-16-065659-1 
517   $aReview of the anti-drug certification process 
606   $aDrug control$zUnited States
606   $aDrug control$xInternational cooperation
606   $aDrug abuse$zUnited States$xPrevention
610   $aDrug control
610   $aDrug abuse
610   $aPolitical science
610   $aPsychology
615  0$aDrug control
615  0$aDrug control$xInternational cooperation.
615  0$aDrug abuse$xPrevention.
676   $a362.29/16
906   $aBOOK
912   $a9910689446103321
996   $aReview of the anti-drug certification process$93096273
997   $aUNINA